CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma

Reda S. Saad, Nadia Ismiil, Valérie Dubé, Sharon Nofech-Mozes, Mahmoud A. Khalifa

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


We studied the expression of cytokeratin (CK) 7, CK20, CDX-2, and p16 in 119 cervical adenocarcinomas (65 usual type [50 invasive; 15 in situ], 37 intestinal type [21 invasive; 16 in situ], 10 endometrioid, 5 adenosquamous, and 2 signet-ring carcinomas) in comparison with 55 cases of rectal adenocarcinomas. The percentage of cells staining was considered negative if 0% to 5% stained; more than 5% was considered positive. For p16, staining of more than 50% was considered positive. CK7 was expressed in all cervical cases and in 12 rectal adenocarcinomas (22%). CK20 was expressed in 17 cervical adenocarcinomas (14.3%) and in 48 rectal adenocarcinomas (87%). CK20 immunostaining was diffuse in the majority of rectal tumors but focal in most cervical tumors. CDX-2 was expressed in all cases of rectal adenocarcinoma and in 46 cervical adenocarcinomas (38.7%): usual type, 10 (15%); intestinal type, 31 (84%); endometrioid type, 5 (50%); adenosquamous and signet-ring types, 0 (0%). CDX-2 is a marker for intestinal differentiation irrespective of a rectal or cervical origin. Therefore, it should not be used as the sole basis to confirm the colorectum as the primary origin in metastatic cases.

Original languageEnglish (US)
Pages (from-to)531-538
Number of pages8
JournalAmerican journal of clinical pathology
Issue number4
StatePublished - Oct 2009


  • CDX-2
  • Cervical adenocarcinoma
  • Intestinal differentiation


Dive into the research topics of 'CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma'. Together they form a unique fingerprint.

Cite this